Publicacions

2017 

Folate deficiency in patients seeking treatment of alcohol use disorder
Sanvisens A, Zuluaga P, Pineda M, Fuster D, Bolao F, Juncà J, Tor J, Muga R
Drug Alcohol Depend 2017;180:417-422

Over-expression of CD8+ T cell activation is associated with decreased CD4+ cells in patients seeking treatment of Alcohol Use Disorder
Zuluaga P, Sanvisens A, Martínez-Cáceres E, Teniente A, Tor J, Muga R
Drug Alcohol Depend 2017;180:7-13

Long-term mortality of patients with an alcohol-related Wernicke-Korsakoff Syndrome.
Sanvisens A, Zuluaga P, Fuster D, Rivas I, Tor J, Marcos M, Chamorro AJ, Muga R
Alcohol Alcohol 2017 Jul 1:52 (4):466-471.
Entrada relacionada

Patients with alcohol use disorder: initial results from a prospective multicenter registry in the Spanish Network on Addiction Disorders. CohRTA Study.

Sanvisens A, Zuluaga P, Rivas I, Rubio G, Gual A, Torrens M, Short A, Álvarez FJ, Tor J, Farré M, Rodríguez de Fonseca F, Muga R y CohRTA.

Adicciones. 2017 Jan 12;0(0):931.

Cannabis as  secondary drug is no associated with a greater risk of death in patients with opiate, cocaine or alcohol dependence.
Fuster D, Sanvisens A, Bolao F, Zuluaga P, Rivas I, Farre M, Tor J, Muga R
J Addict Med 2017; Jan/Feb 11(1):34-39

Entrada relacionada

2016

Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections.

Fuster D, Sanvisens A, Bolao F, Rivas I, Tor J, Muga R.

World J Hepatol. 2016 Nov 8;8(31):1295-1308. Review.

Entrada relacionada

Wide array of T-cell subpopulation alterations in patients with alcohol use disorders.

Zuluaga P, Sanvisens A, Teniente A, Fuster D, Tor J, Martínez-Cáceres E, Muga R.

Drug Alcohol Depend. 2016 May 1;162:124-9.

Alcohol Consumption during Pregnancy: Analysis of Two Direct Metabolites of Ethanol in Meconium.

Sanvisens A, Robert N, Hernández JM, Zuluaga P, Farré M, Coroleu W, Serra M, Tor J, Muga R.
Int J Mol Sci. 2016 Mar 22;17(3) 

Entrada relacionada

2015

Hepatitis C associated to substance abuse: ever closer to a treatment without Interferon.

Muga R, Zuluaga P, Sanvisens A, Rivas I, Fuster D, Bolao F, Tor J, Red de Trastornos Adictivos-Rta

Adicciones. 2015 Jun 17;27(2):141-149
Entrada relacionada

Markers of inflammation and mortality in a cohort of patients with alcohol dependence.

Fuster D, Sanvisens A, Bolao F, Zuluaga P, Rivas I, Tor J, Muga R.

Medicine (Baltimore). 2015 Mar;94(10):e607.

Entrada relacionada
 
Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patients.

Fuster D, Sanvisens A, Bolao F, Serra I, Rivas I, Tor J, Muga R

J Viral Hepat 2015;22:18-24 

Entrada relacionada

2014

Sex-specific disease outcomes of HIV-positive and HIV-negative drug users admitted to an opioid substitution therapy program in Spain: a cohort study.

Muga R, Rivas I, Faure E, Fuster D, Zuluaga P, Rubio M, Muñoz T, Torrens M, Tor J, Sanvisens A.

BMC Infect Dis. 2014;14:504

Entrada relacionada

Temporal trends in the survival of drug and alcohol abusers according to the primary drug of admission to treatment in Spain.

Sanvisens A, Vallecillo G, Bolao F, Rivas I, Fonseca F, Fuster D, Torrens M, Pérez-Hoyos S, Pujol R, Tor J, Muga R.

Drug Alcohol Depend. 2014;136:115-20

Entrada relacionada

[Characteristics of heroin dependent patients admitted to a methadone treatment program].

Sanvisens A, Rivas I, Faure E, Muñoz T, Rubio M, Fuster D, Tor J, Muga R.

Med Clin (Barc). 2014 Jan 21;142(2):53-8

Entrada relacionada

Recull d'altres publicacions del grup.